Fitzsimons, EJ;
Cullis, JO;
Thomas, DW;
Tsochatzis, E;
Griffiths, WJH;
British Society for Haematology, .;
(2018)
Diagnosis and therapy of genetic haemochromatosis (review and 2017 update).
[Editorial comment].
British Journal of Haematology
, 181
(3)
pp. 293-303.
10.1111/bjh.15164.
Preview |
Text
Fitzsimmons_Diagnosis_therapy_genetic.pdf - Accepted Version Download (226kB) | Preview |
Abstract
Genetic haemochromatosis (GH) is one of the most frequentgenetic disorders found in Northern Europeans. GH is a condition caused by continued absorption of iron from the upper small intestine, despite normal, and then increased, total body iron. This leads to accumulation of iron in the tissues as the body has no means of getting rid of excess iron.In advanced disease, iron accumulation causes widespread tissue damage, including diabetes mellitus and cirrhosis. The disorder is inherited in autosomal recessive fashion. The gene involved lies close to the HLA-A region on chromosome 6. This updated guideline follows on from the previously published guideline commissioned by the British Committee forStandards in Haematology in February 2000 (Dooley & Wor-wood, 2000). This review and updated guidance coincides with the development of a separate guideline on the investigation and management of a raised serum ferritin, also commissioned by the BSH guidelines committee.
Archive Staff Only
 |
View Item |
